Skip to main content

Table 3 Comparison of the average period until normalization of hepatic enzymes in the severe DIH and its HREZ regimen group

From: Effectiveness of hepatoprotective drugs for anti-tuberculosis drug-induced hepatotoxicity: a retrospective analysis

  Patients who have stopped anti-TB drugs and with hepatoprotective drugs Patients who have stopped anti-TB drugs and without hepatoprotective drugs P value
severe DIH group 21 ± 10 days
(N = 17)
21 ± 11 days
(N = 6)
0.97
HREZ group 21 ± 8 days
(N = 11)
24 ± 10 days
(N = 5)
0.64
  1. Data are expressed as means ± standard error
  2. Abbreviations: H isoniazid, R rifampicin, E ethambutol, Z pyrazinamide